CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab
Neurol Clin Pract
.
2019 Jun;9(3):273-276.
doi: 10.1212/CPJ.0000000000000639.
Authors
Murtaza Khan
1
,
Douglas E Ney
1
,
Bette K Kleinschmidt-DeMasters
1
,
Lindsay Horton
1
,
Enrique Alvarez
1
,
Amanda L Piquet
1
Affiliation
1
Department of Neurology (MK, DEN, BKK-D, LH, EA, ALP), Department of Neurosurgery (DEN, BKK-D), and Department of Pathology (BKK-D), University of Colorado, Aurora, CO.
PMID:
31341717
PMCID:
PMC6615657
DOI:
10.1212/CPJ.0000000000000639
No abstract available
Publication types
Case Reports